he sure was singing a different song a few weeks back when things were going good! You are a fine one to preach to folks who are now complaining after losing their shirts on this POS. Perhaps their losses are due to your irrational exuberance? Remember your earlier posts? I do.
----------------------------------------------- HOLD OR SELL SCLN by: WillRogersJunior [ Ignore ] 3/8/00 12:28 am Msg: 7618 of 9836 In my opinion the risk of this stock running away is to great. When the "Smart Money" realizes that a potential billion dollar a year drug coupled with a 20% to 25% profit margin makes SCLN a strong buy at $40 or $50, watch out.
I have been telling a friend of mine about SCLN for several months since it was about $6. He keeps waiting for a pull back. Why worry about a point or two when we stand to make 3 to 5 times our money at these levels.
If the stock goes to $50, I owe my wife a Chysler 300M. I hope I have to buy that car very soon.
I'm still here and smiling from ear to ear. Oh, thank God I learned about SCLN from the Red Chip Review.
I believe in everything I said back then. I believe SCLN is going to $50 a share. What I could not see was a correction in the biotech sector. This and the correction in the Russell 2000 is all that is holding us back.
I am now of the opinion that it will take some time to recover lost ground. I think investors better plan on six months.
I could be wrong of course. Unforseen events could propel the stock forward. I just don't know what they might be at this juncture.
I just don't think we can get a recovery before a general sector recovery. Another one of my investments - AKRN - got brokerage coverage today. The stock moved up a little, but not like it would have 3 weeks ago.
I am hoping for realism on the SCLN now. Hopefully, long-term investors will hunker down and build the base I have been talking about. We need a base to begin the ascent. It would be nice to see a base before the next earnings release.
"I believe in everything I said back then. I believe SCLN is going to $50 a share. What I could not see was a correction in the biotech sector. This and the correction in the Russell 2000 is all that is holding us back." Isn't this a little bit like asking Mrs. Lincoln whether, aside from the slight disturbance by Mr. Boothe, she enjoyed the play?